# CES4A

## Overview
Carboxylesterase 4A (CES4A) is a gene that encodes the enzyme carboxylesterase 4A, which belongs to the carboxylesterase family of enzymes. These enzymes are primarily involved in the hydrolysis of ester and amide bonds, playing a crucial role in the metabolism of various xenobiotics and endogenous substrates. The CES4A gene is expressed in multiple tissues and is subject to complex regulatory mechanisms, including epigenetic modifications and post-translational changes, which influence its activity and function. The protein product, carboxylesterase 4A, is characterized by a specific three-dimensional structure that is essential for its enzymatic activity and interaction with substrates. Alterations in CES4A expression and function have been implicated in several diseases, including hepatocellular carcinoma and ovarian cancer, where it may contribute to drug resistance and tumor progression (Asante2020Liquid; Rassek2020SingleCell; Demir2022Implications).

## Structure
Carboxylesterase 4A (CES4A) is an enzyme characterized by its complex molecular structure, which is essential for its function in hydrolyzing ester and amide bonds. The primary structure of CES4A is composed of a specific sequence of amino acids that form its polypeptide chain. This sequence determines the enzyme's unique properties and functionality. The secondary structure of CES4A includes alpha-helices and beta-sheets, which contribute to the overall stability of the protein. These structural elements are crucial for maintaining the enzyme's integrity and facilitating its catalytic activity.

The tertiary structure of CES4A involves the three-dimensional folding of the protein, which is vital for its enzymatic activity. This folding allows the enzyme to adopt a specific conformation necessary for substrate binding and catalysis. CES4A may also form quaternary structures through the assembly of multiple subunits, although specific details on this aspect are not provided in the context.

Post-translational modifications such as glycosylation and phosphorylation are common in CES4A and can influence the enzyme's function and localization. These modifications may affect the enzyme's stability, activity, and interaction with other cellular components, highlighting their importance in the regulation of CES4A's biological roles.

## Clinical Significance
CES4A (carboxylesterase 4A) is implicated in various diseases and conditions through alterations in its expression and interactions. In hepatocellular carcinoma (HCC), CES4A is hypermethylated, suggesting an epigenetic regulation that may increase cellular vulnerability to xenobiotics. This hypermethylation, combined with posttranscriptional suppression by miR3653, represents a dual epigenetic control mechanism that could weaken the host defense system, potentially aiding in carcinogenesis (Demir2022Implications).

In ovarian cancer, CES4A mutations are associated with resistance to treatments such as cisplatin, paclitaxel, and liposomal doxorubicin. The analysis of circulating tumor DNA (ctDNA) has identified CES4A among the gene mutations that confer treatment resistance, highlighting its role in the management of recurrent cancers (Asante2020Liquid).

In cutaneous T-cell lymphomas (CTCLs), CES4A is part of unique gene expression clusters identified in advanced skin samples. These clusters are linked to tumor-specific pathways involved in cell survival, proliferation, and metastasis, indicating CES4A's involvement in the complexity and heterogeneity of CTCLs (Rassek2020SingleCell).


## References


[1. (Asante2020Liquid) Du-Bois Asante, Leslie Calapre, Melanie Ziman, Tarek M. Meniawy, and Elin S. Gray. Liquid biopsy in ovarian cancer using circulating tumor dna and cells: ready for prime time? Cancer Letters, 468:59–71, January 2020. URL: http://dx.doi.org/10.1016/j.canlet.2019.10.014, doi:10.1016/j.canlet.2019.10.014. This article has 123 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.canlet.2019.10.014)

[2. (Rassek2020SingleCell) Karolina Rassek and Katarzyna Iżykowska. Single-cell heterogeneity of cutaneous t-cell lymphomas revealed using rna-seq technologies. Cancers, 12(8):2129, July 2020. URL: http://dx.doi.org/10.3390/cancers12082129, doi:10.3390/cancers12082129. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers12082129)

[3. (Demir2022Implications) Ayse Banu Demir, Domenico Benvenuto, Bilge Karacicek, Yasemin Erac, Silvia Spoto, Silvia Angeletti, Massimo Ciccozzi, and Metiner Tosun. Implications of possible hbv-driven regulation of gene expression in stem cell-like subpopulation of huh-7 hepatocellular carcinoma cell line. Journal of Personalized Medicine, 12(12):2065, December 2022. URL: http://dx.doi.org/10.3390/jpm12122065, doi:10.3390/jpm12122065. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/jpm12122065)